ANTHONY TRINH and 123Herbals LLC are recalling Silintan (25 count) because FDA testing found it contains undeclared meloxicam. Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) that was not listed on the label and is being marketed without FDA approval. Consumers should contact their healthcare provider or pharmacist if they have used this product.
The undeclared meloxicam can cause serious side effects, including gastrointestinal bleeding, cardiovascular risks like heart attack or stroke, and kidney damage. These risks are significantly increased for consumers already taking other NSAIDs or prescription blood thinners.
You have 2 options:
Shanghai Chinese Medical Works, Shanghai, China; Recall #: D-0388-2026
Front of package, Silintan dietary supplement pills
Back of package, Silintan dietary supplement pills
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.